Presenting Innovation in Medical Care Standards for Traffic Accident Victims, Jasa Raharja Wins Award at the 2024 Asia Awards
Singapore, Metropolitanpost.id
Jasa Raharja has successfully won an award from the Insurance Asia Awards 2024 in the category of “The Strategic Partnership of The Year” with the strategic initiative of Jasa Raharja’s Injury Diagnosis, National Medical Formulary and Compendium (DCFKMN-JR).
Starting in 2023, Jasa Raharja addressed the lack of standard care for traffic accident victims by forming a Medical Advisory Board (MAB) to standardize DC-FKMN-JR which is a standard protocol for injury diagnosis, medicines, and medical equipment. This initiative ensures optimal treatment costs and quality control for accident victims throughout Indonesia. Through AI technology embedded in the JRCare application, DC-FKMN-JR is able to simplify and improve claim verification.
In the appreciation event held at the Marina Bay Sands Expo and Convention Center, Singapore, on Tuesday (09/07/2024), Jasa Raharja President Director Rivan A. Purwantono was present, and the award was received by Jasa Raharja’s Operational Director, Dewi Aryani Suzana accompanied by the Head of the Service Division, Head of the Insurance Division and the Corporate Secretary.
Jasa Raharja’s President Director, Rivan A. Purwantono, said that as a state-owned company, Jasa Raharja continues to strive to improve corporate performance in order to provide the best service to the public, and to be able to compete with global companies.
This award is a reflection that Jasa Raharja is able to become a leading insurance company in the country and Asia. This achievement is certainly achieved thanks to the hard work of the company’s ranks and the support of all stakeholders which will continue to be improved in the future.
Insurance Asia Awards is one of the prestigious events in the Asia Pacific region that gives awards to insurance companies that have achieved extraordinary achievements, set new benchmarks, and demonstrated innovation in the industry.
